Methicillin‐resistant staphylococcus aureus

In-Vitro Activity of Teicoplanin against Clinical MethicillinResistant Staphylococcus aureus Isolates. J Microbiol Biotechnol, 2017, 2(1): 000112

Aim: To evaluate the in vitro activity of teicoplanin against clinical methicillin resistant Staphylococcus aureus isolates was the aim of this study Methods and Material: A total of 62 previously confirmed MRSA isolates were included in this study. Susceptibility testing and result interpretation of isolates to teicoplanin was performed by the E test and disk diffusion method as per Clinical a...

Staphylococcus aureus

Staphylococcus aureus

Staphylococcus aureus is a bacterium that is a member of the Firmicutes, and is frequently found in the human respiratory tract and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections (e.g. boils), respiratory disease (e.g. sinusitis), and food poisoning. Disease-associated strains often promote infections by producing potent protein toxins, and exp...

Staphylococcus Aureus

To date, 21 different staphylococcal enterotoxins have been described (known by letters of the alphabet, A V, although a few letters are missing from the sequence). All are heat stable, water-soluble proteins and retain their activity in the digestive tract after ingestion. Staphylococcal enterotoxin A (SEA), either alone, or in combination with other staphylococcal enterotoxins, is the one mos...

Reduced sensitivity of staphylococcus aureus to vancomycin

Introduction: Staphylococcus aureus is one of the most common causes of infections in hospitals and vancomycin is used for the treatment of methicillin resistant S, aureus infections. Therefore, imergence of Staphylococcus aureus with reduced sensitivity to vancomycin is a serious problem. The aim of this study was to investigate the prevalence of Staphylococcus aureus with reduced suscep...